MMR, about 88% effective against mumps. When everyone has the vaccine, its very effective at keeping mumps out of the community. TDAP, 80-90%. This is part of why I asked about your background. If your understanding of vaccines is that they need to be 98% effective on every individual to be a "real" vaccine then you're dealing with a bad data set. You're infantry, great, me too. We both know what happens when you try to build a mission off bad intel.
First off, my apologies for the length of this. It's not all particularly directed at you, I got to writing and went way beyond the scope of your questions. Had a lot on my mind....
MMR effectiveness: That's a fair point; my spitball estimate was high. But that is also 3-fer vaccine; it 88% effective against mumps, but also 93% effective against measles, and 97% against rubella. More importantly, unlike COVID, the MMR vaccine efficacy lasts... you only take the MMR shot twice. Not now and then every 6 months until forever.
From what I understand, measles vaccines have been through multiple recalls and reformulations. I sincerely hope the COVID shots improve.
BTW, I'm still on the line at 46, by choice, and haven't slowed down. You're absolutely right about intel. But also, to get good intel and SA, you also need to check in with guys on the ground....and a reasonable sampling of all the guys on the ground. Even the ones you're told are nuts. That real world observation is (at least) a sanity check against the received wisdom from the experts...be they brigade S-2, or the CDC. And obviously, that means listening to ICU docs, but it also means the loners out there who have been hurt by the injections, the docs and nurses too scared to speak up, the maverick FLCCC types, your neighbors, friendly EMTs and first responders. All of that experience needs to be weighed and evaluated. The authority's expert and supposedly scientific analysis, no matter how sophisticated, isn't going to always be sufficient.
mRNA COVID-19 vaccines are highly effective at preventing severe outcomes and death caused by the SARS-CoV-2 Delta variant (B.1.617.2) in Qatar despite substantially lower effectiveness at blocking infection.
www.nature.com
This study is showing above 90% against the Delta variant, dunno where you're getting 50%.
Fair enough. We're talking about different definitions of effectiveness. And largely about protection vs immunization. Here, they are defining effectiveness as prevention of severe outcome or death. And by that measure, the data seems fair, and conclusions reasonable....given the conditions of the study, at the time of the study. Particularly since, in this study, we're talking about a pretty young population (only 9% above age 50). The US population is something like 30+% over 50. Presumably that would decrease protection against serious illness...which sounds about right.
I'm glad the mRNA injections are largely protective. My big concern now is how effective are the COVID injections at immunization and preventing transmission.
We've been sold the idea that the only way to stop the spread is for everyone to get vaccinated.
"Do your part, get vaccinated to protect others."
Is "vaccination" stopping the spread? How's that working out? Does anybody really still think it's 90% effective at stopping delta (and whatever is coming next) infection and transmission in the real world right now? Look around.
Here's a particular study I was thinking of,
Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to August 13, 2021
National data on COVID-19 vaccine breakthrough infections is inadequate but urgently needed to determine U.S. policy during the emergence of the Delta variant. We address this gap by comparing SARS CoV-2 infection by vaccination status from February 1, 2021 to August 13, 2021 in the Veterans...
www.medrxiv.org
It deals with waining effectiveness of the 3 big COVID shots in the U.S., and it paints quite a bit worse picture. Efficacy here is defined as prevention of symptomatic COVID. Basically any illness, not just severe. Which is important to me, because that presumably gives an indication of COVID infection transmission after vaccination.
The short version, efficacy dropped from basically 94% percent overall (March 2021) down to 54% by August. Moderna dropped to 64%, Pfizer 50%, and Janssen to 3%. This is largely attributed to the the variant change (Delta variant). Again, all the usual caveats...that's for the conditions at the time. There's no reasons to assume the authors of this study are "anti mRNA vaxers". Granted, with the subject population being veterans, that's likely more immunocompromised ....but that older population is largely the vulnerable one I care about.
Note, that data was from August. Is there any reason to think the efficacy of the injections, that were made for the alpha variant, has improved since then?
Again, that's 54% prevention of symptomatic COVID. But transmission doesn't require symptomatic cases, so transmissibility is likely worse.
I rounded to 50%, because it's an impossibly developing situation, with too many variables, and the data was from back in August. It's a moving target: What population are we talking about, when were they vaccinated (what percentage Pfizer, vs Moderna vs J&J), what's the interval between doses, what was the dosage, what is the state of the population's immune system, what % had previous infection, % immunocompromised (and how, and to what extent), and what specific variants or sub-variants are we talking about?
Infectiousness/transmissibility is my big concern.
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant
We found no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the substantial proportion of asymptomatic vaccine breakthrough cases with high viral levels, interventions, including...
www.medrxiv.org
The results of this study seem to jive with experience in Boston and Gibraltar lately. As well as just casual observation. As good a thing as the "vaccines" are at protecting the individual who takes it, it doesn't appear that taking the vaccine does that much (if anything) to protect others. That's my big concern.
Now, maybe the study's conclusions aren't precisely true. Maybe there is a statistically significant difference in viral load. OK, how big a difference? Enough to mandate "vaccination" of the young and healthy, over whatever the unknown risk of now until forever boosters? What about those that have already recovered? Is the risk reward worth it?